311 related articles for article (PubMed ID: 9382748)
21. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
Savoia D; Deplano C; Zucca M
Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
[TBL] [Abstract][Full Text] [Related]
22. Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis.
Hoiby N
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):541-50. PubMed ID: 4153350
[No Abstract] [Full Text] [Related]
23. [Iron deficiency and Pseudomonas aeruginosa colonization in cystic fibrosis].
de Montalembert M; Fauchère JL; Bourdon R; Lenoir G; Rey J
Arch Fr Pediatr; 1989 May; 46(5):331-4. PubMed ID: 2504126
[TBL] [Abstract][Full Text] [Related]
24. [Bacteriology of mucoviscidosis during a 5-year period].
Ferrer A; Tórtola MT; Cobos N; González T; Fernández F
Enferm Infecc Microbiol Clin; 1992 Jan; 10(1):34-8. PubMed ID: 1498172
[TBL] [Abstract][Full Text] [Related]
25. Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections.
Beckmann C; Brittnacher M; Ernst R; Mayer-Hamblett N; Miller SI; Burns JL
Infect Immun; 2005 Jan; 73(1):444-52. PubMed ID: 15618183
[TBL] [Abstract][Full Text] [Related]
26. Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis.
Govan JR; Harris GS
Microbiol Sci; 1986 Oct; 3(10):302-8. PubMed ID: 3155268
[TBL] [Abstract][Full Text] [Related]
27. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis.
Milagres LG; Castro TL; Garcia D; Cruz AC; Higa L; Folescu T; Marques EA
Pediatr Pulmonol; 2009 Apr; 44(4):392-401. PubMed ID: 19283764
[TBL] [Abstract][Full Text] [Related]
28. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ
J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821
[TBL] [Abstract][Full Text] [Related]
29. [Pseudomonas aeruginosa and cystic fibrosis: first colonization to chronic infection].
Laurans M; Arion A; Fines-Guyon M; Regeasse A; Brouard J; Leclercq R; Duhamel JF
Arch Pediatr; 2006 Oct; 13 Suppl 1():S22-9. PubMed ID: 17370393
[TBL] [Abstract][Full Text] [Related]
30. [Slime from a mucoid strain of Pseudomonas aeruginosa in mucoviscidosis and other respiratory diseases (author's transl)].
Marty N; Lapchine L; Pradere J; Dutau G
Ann Pediatr (Paris); 1981 Apr; 28(4):261-5. PubMed ID: 6784657
[No Abstract] [Full Text] [Related]
31. Pseudomonas aeruginosa infection in cystic fibrosis. Distribution of B and T lymphocytes in relation to the humoral immune response.
Hoiby N; Mathiesen L
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):559-66. PubMed ID: 4213329
[No Abstract] [Full Text] [Related]
32. Vaccine strategies against Pseudomonas aeruginosa infection in the lung.
Cripps AW; Dunkley ML; Clancy RL; Kyd J
Behring Inst Mitt; 1997 Feb; (98):262-8. PubMed ID: 9382749
[TBL] [Abstract][Full Text] [Related]
33. Persistence of Pseudomonas aeruginosa strains in seven cystic fibrosis patients followed over 20 months.
Godard C; Plesiat P; Michel-Briand Y
Eur J Med; 1993 Feb; 2(2):117-20. PubMed ID: 8258014
[No Abstract] [Full Text] [Related]
34. [Bacteriologic surveillance of the sputum of 22 patients with mucoviscidosis].
Feigelson J; Pecau Y
Arch Fr Pediatr; 1967 Dec; 24(10):1135-47. PubMed ID: 5590823
[No Abstract] [Full Text] [Related]
35. Evaluation of specific immune response in early P. aeruginosa infection in cystic fibrosis patients.
Dolce D; Cariani L; Campana S; Ravenni N; Mergni G; Biffi A; Colombo C; Gagliardini R; Cirilli N; Manso E; Padoan R; Soncini E; Forte FR; D'Aprile A; Ratclif L; Amboni M; Casciaro R; Minicucci L; Borio T; Cosimi A; Vieni G; Zinnarello C; Fiscarelli E; Collura M; Pensabene T; Braggion C; Döring G; Taccetti G
J Cyst Fibros; 2014 Jan; 13(1):116-7. PubMed ID: 24022018
[No Abstract] [Full Text] [Related]
36. A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients.
Laine L; Perry JD; Lee J; Oliver M; James AL; De La Foata C; Halimi D; Orenga S; Galloway A; Gould FK
J Cyst Fibros; 2009 Mar; 8(2):143-9. PubMed ID: 19097827
[TBL] [Abstract][Full Text] [Related]
37. Bacterial infection in cystic fibrosis.
May JR; Herrick NC; Thompson D
Arch Dis Child; 1972 Dec; 47(256):908-13. PubMed ID: 4630478
[TBL] [Abstract][Full Text] [Related]
38. Precipitating Pseudomonas aeruginosa antibodies and antimicrobial therapy in cystic fibrosis patients.
Trancassini M; de Vito D; Cimino G; Antonelli M; Quattrucci S; Cipriani P
Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):309-12. PubMed ID: 8781882
[TBL] [Abstract][Full Text] [Related]
39. [Production of elastase, exotoxin A and alkaline protease during bronchopulmonary exacerbations in patients with mucoviscidosis chronically infected by Pseudomonas aeruginosa].
Jaffar-Bandjee MC; Carrere J; Bally M; Chazalette JP; Galabert C
Pathol Biol (Paris); 1994 May; 42(5):505-9. PubMed ID: 7824322
[TBL] [Abstract][Full Text] [Related]
40. [Microbiological study of the respiratory tract in children with cystic fibrosis].
Muñoz C; Juncosa T; Gené A; Fortea J; Séculi JL; Latorre C
Enferm Infecc Microbiol Clin; 1996 Mar; 14(3):142-4. PubMed ID: 8695681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
